SCHEMBL27644496

SCHEMBL27644496

O=C(Nn1ccc2ncccc21)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 2/20 0.48
▸ PABPC1 P11940 1/20 0.45
▸ SLC22A12 Q96S37 1/20 0.42
▸ RPS6KA5 O75582 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ RAB9A P51151 5/20 0.40
▸ NPC1 O15118 4/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ KDR P35968 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ HPGDS O60760 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ PKM P14618 1/20 0.39
▸ KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3219730 0.77 HPGDS (0.70) ALDH1A1HSD17B10HPGDSHTTKMT2A
SCHEMBL3219716 0.76 GRIN2B (0.41) CYP3A4HPGDS
SCHEMBL16554573 0.75 ALOX15 (0.54) CYP3A4CYP2C19RAB9ANPC1ALOX15
SCHEMBL4714519 0.74 SLC22A12 (0.66) METSLC22A12RPS6KA5RAB9ANPC1
SCHEMBL3224764 0.71 HPGDS (0.55) CYP3A4CYP2C9CYP2C19ALDH1A1HPGDS
SCHEMBL3217959 0.70 HPGDS (0.52) RAB9AHPGDS
SCHEMBL11206432 0.70 KMT2A (0.59) CYP3A4CYP2C9CYP2C19RAB9ANPC1
SCHEMBL30241905 0.69 SLC22A12 (0.56) METSLC22A12RPS6KA5SMN1; SMN2
SCHEMBL288413 0.69 SLC22A12 (0.56) METSLC22A12RPS6KA5SMN1; SMN2
SCHEMBL30532842 0.68 SLC22A12 (0.55) METSLC22A12RPS6KA5SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101528215-B Combination of CHK1 inhibitor and cyclodextrin ICOS CORP 2011-10-19 — — CN disclosed
CN-101528215-A Composition of CHKL inhibitor and cyclodextrin ICOS CORP (US) 2009-09-09 — — CN disclosed
CN-1882342-A Use of CHK1 inhibitors to control cell proliferation ICOS CORP (US) 2006-12-20 — — CN disclosed
Send feedback